ChromaDex Corp (CDXC, Financial) is set to release its Q4 2024 earnings on March 4, 2025. The consensus estimate for Q4 2024 revenue is $26.73 million, and earnings are expected to come in at $0.02 per share. The full year 2024's revenue is expected to be $97.20 million, and the earnings are expected to be $0.04 per share. More detailed estimate data can be found on the Forecast page.
ChromaDex Corp (CDXC, Financial) Estimates Trends
Revenue estimates for ChromaDex Corp (CDXC) have remained steady at $97.20 million for the full year 2024 and $0.12 billion for 2025 over the past 90 days. Earnings estimates for ChromaDex Corp (CDXC) have also remained consistent at $0.04 per share for the full year 2024 and $0.12 per share for 2025 over the past 90 days.
ChromaDex Corp (CDXC, Financial) Reported History
In the previous quarter ending September 30, 2024, ChromaDex Corp's (CDXC) actual revenue was $25.58 million, which beat analysts' revenue expectations of $23.64 million by 8.19%. ChromaDex Corp's (CDXC) actual earnings were $0.02 per share, which exceeded analysts' earnings expectations of $0.003 per share by 566.67%. After releasing the results, ChromaDex Corp (CDXC) was up by 67.91% in one day.
ChromaDex Corp (CDXC, Financial) 12 Month Price Targets
Based on the one-year price targets offered by four analysts, the average target price for ChromaDex Corp (CDXC) is $7.70 with a high estimate of $8.00 and a low estimate of $6.80. The average target implies an upside of 36.52% from the current price of $5.64.
Based on GuruFocus estimates, the estimated GF Value for ChromaDex Corp (CDXC, Financial) in one year is $2.73, suggesting a downside of -51.60% from the current price of $5.64.
Based on the consensus recommendation from three brokerage firms, ChromaDex Corp's (CDXC, Financial) average brokerage recommendation is currently 1.7, indicating an "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
